NFKB1 and neoplasm: Lung cancer-derived TEVs can deliver miR-21 and miR-29a to macrophage activating TLR8 and the NFKB pathway and leading to the secretion of IL6 and TFNA with associated pro-tumor inflammatory environment [110].